Concepedia

C R Divgi

CR

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

1989

Affiliations

Cornell University(Current)

Memorial Sloan Kettering Cancer Center

Ludwig Cancer Research

Ludwig Cancer Research

C R Divgi is an author at Cornell University specializing in oncology, medicine, and administration of monoclonal antibodies.

Publications per year

1989–2015

10

Publications

10

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

Andrew M. Scott, G. Wiseman, Sydney Welt et al. · PubMed · 2003 · 442 citations

, , +17

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.

S Welt, C R Divgi, Andrew M. Scott et al. · Journal of Clinical Oncology · 1994 · 262 citations

, , +17

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.

Egbert Oosterwijk, Neil H. Bander, C R Divgi et al. · Journal of Clinical Oncology · 1993 · 182 citations

, , +17

Imaging of Human Tumor Xenografts With an Indium-111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody

Alec Goldenberg, Hideo Masui, C R Divgi et al. · JNCI Journal of the National Cancer Institute · 1989 · 99 citations

, , +13

Cross-sectional and Test-Retest Characterization of PET with [18F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes

Matthew Freeby, P. Kringas, Robin Goland et al. · Molecular Imaging and Biology · 2015 · 32 citations · Full text

, , +14

1–5 of 10